Trial intelligence / Profile preview

Adipose stem cell-seeded bone substitute for maxillary sinus floor elevation

NL-OMON35169Not yet recruiting

Sponsor
VU University medical center, De Boelelaan 1117, 1081 HV Amsterdam
Start
May 2010
Modality
Stem Cell Therapies → Cell Therapies
Countries
1
01

Overview

Open-label, single-arm trial of adipose derived mesenchymal stromal cells in Maxillary atrophy, sponsored by VU University medical center, De Boelelaan 1117, 1081 HV Amsterdam. Primary endpoint: Safety. Planned start May 2010; status: not yet recruiting.

02

Drugs

adipose derived mesenchymal stromal cells
03

Conditions

Maxillary atrophy

Beyond the preview

Go deeper on NL-OMON35169.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON35169.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call